A Novel E-health Platform (PWG)
A Randomized Trial of a Novel E-health Platform (Plan Well GuideTM)
Sponsor: Daren K. Heyland
Terminated
Unable to enroll enough patients in the time allotted. Study deemed infeasible.Dece
Other terminated trials from Daren K. Heyland
More terminations from Daren K. Heyland
Listed as NCT05024903, this PHASE2/PHASE3 trial focuses on Aging Well and Decision Making and remains terminated or withdrawn. Sponsored by Daren K. Heyland, it has been updated 6 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jun 2023 — Jul 2024 [monthly]
Terminated PHASE2_PHASE3
Status: Recruiting → Terminated
-
Apr 2022 — Jun 2023 [monthly]
Recruiting PHASE2_PHASE3
Status: Not Yet Recruiting → Recruiting
-
Oct 2021 — Apr 2022 [monthly]
Not Yet Recruiting PHASE2_PHASE3
▶ Show 1 earlier version
-
Sep 2021 — Oct 2021 [monthly]
Not Yet Recruiting PHASE2_PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Daren K. Heyland
For direct contact, visit the study record on ClinicalTrials.gov .